erickdoox
Iron
- Joined
- Nov 9, 2025
- Posts
- 206
- Reputation
- 236
I am looking for a technical assessment of the synergy between MK-677 (Ibutamoren) and localized bonesmashing. There is no larping here—either the biochemical pathways facilitate appositional growth post-16, or they don't.
The hypothesis is straightforward: MK-677 acts as a potent secretagogue for Growth Hormone (GH) and IGF-1. While linear growth is restricted by epiphyseal closure, the periosteum remains responsive to mechanical loading throughout the life cycle via mechanotransduction.
The hypothesis is straightforward: MK-677 acts as a potent secretagogue for Growth Hormone (GH) and IGF-1. While linear growth is restricted by epiphyseal closure, the periosteum remains responsive to mechanical loading throughout the life cycle via mechanotransduction.
- Mechanical Trigger: High-velocity loading (smashing) induces localized sclerostin inhibition, activating the Wnt/β-catenin pathway—the primary signal for bone deposition.
- Systemic Supply: Elevated IGF-1 levels increase the proliferation of osteoprogenitor cells and stimulate osteoblasts to synthesize bone matrix at the site of trauma.